Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
ALLERGENIC EXTRACTSINDIVIDUAL TREATMENT VIAL
Medication labelWhy this: Advisory · dailymed-other
When the natural exposure to elevated aeroallergens produces symptoms as described under Clinical Pharmacology, specific diagnosis and therapeutic procedures are indicated. Clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. Diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. Specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. When immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. An orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 THIS PRODUCT IS NOT INTENDED FOR TREATMENT OF PATIENTS WHO DO NOT MANIFEST IMMEDIATE HYPERSENSITIVITY REACTIONS TO THE ALLERGENIC EXTRACT FOLLOWING SKIN TESTING.
- generic_name
- treatment set ts348237
- brand_name
- Treatment Set TS348283, Treatment Set TS348334, Treatment Set TS348335, Treatment Set TS348402, Treatment Set TS348403, Treatment Set TS348404, Treatment Set TS348405, Treatment Set TS348490, Treatment Set TS348491, Treatment Set TS348467, Treatment Set TS348560, Treatment Set TS348562, Treatment Set TS348650, Treatment Set TS348651, Treatment Set TS348563, Treatment Set TS348982, Treatment Set TS349185, Treatment Set TS349186, Treatment Set TS349163, Treatment Set TS349162, Treatment Set TS349274, Treatment Set TS349290, Treatment Set TS349291, Treatment Set TS349357, Treatment Set TS349358, Treatment Set TS349573, Treatment Set TS349574, Treatment Set TS349575, Treatment Set TS349576, Treatment Set TS349577, Treatment Set TS349631, Treatment Set TS349632, Treatment Set TS349705
- product_names
- Treatment Set TS348237, Treatment Set TS348283, Treatment Set TS348334, Treatment Set TS348335, Treatment Set TS348402, Treatment Set TS348403, Treatment Set TS348404, Treatment Set TS348405, Treatment Set TS348490, Treatment Set TS348491, Treatment Set TS348467, Treatment Set TS348560, Treatment Set TS348562, Treatment Set TS348650, Treatment Set TS348651, Treatment Set TS348563, Treatment Set TS348982, Treatment Set TS349185, Treatment Set TS349186, Treatment Set TS349163, Treatment Set TS349162, Treatment Set TS349274, Treatment Set TS349290, Treatment Set TS349291, Treatment Set TS349357, Treatment Set TS349358, Treatment Set TS349573, Treatment Set TS349574, Treatment Set TS349575, Treatment Set TS349576, Treatment Set TS349577, Treatment Set TS349631, Treatment Set TS349632, Treatment Set TS349705
- ndc
- 49288-0888, 49288-0888-3, 49288-0889, 49288-0889-3, 49288-0890, 49288-0890-3, 49288-0891, 49288-0891-3, 49288-0892, 49288-0892-3, 49288-0893, 49288-0893-3, 49288-0894, 49288-0894-3, 49288-0895, 49288-0895-3, 49288-0897, 49288-0897-3, 49288-0898, 49288-0898-3, 49288-0896, 49288-0896-3, 49288-0899, 49288-0899-3, 49288-0900, 49288-0900-3, 49288-0902, 49288-0902-3, 49288-0903, 49288-0903-3, 49288-0901, 49288-0901-3, 49288-0904, 49288-0904-3, 49288-0905, 49288-0905-3, 49288-0906, 49288-0906-3, 49288-0907, 49288-0907-3, 49288-0908, 49288-0908-3, 49288-0909, 49288-0909-3, 49288-0910, 49288-0910-3, 49288-0911, 49288-0911-3, 49288-0912, 49288-0912-3, 49288-0913, 49288-0913-3, 49288-0914, 49288-0914-3, 49288-0915, 49288-0915-3, 49288-0916, 49288-0916-3, 49288-0917, 49288-0917-3, 49288-0918, 49288-0918-3, 49288-0919, 49288-0919-3, 49288-0920, 49288-0920-3, 49288-0921, 49288-0921-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en